Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

Overview of attention for article published in The Lancet Respiratory Medicine, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source
twitter: 14 X users

facebook: 2 Facebook pages
guideline: 2 clinical guideline sources

Readers on

mendeley: 145 Mendeley

So far, Altmetric has seen 15 X posts from 14 X users, with an upper bound of 171,290 followers.

RT @peripatetical: For influenza, small trials in hospitalized patients using immune plasma as treatment haven't shown much clinical benefi…

For influenza, small trials in hospitalized patients using immune plasma as treatment haven't shown much clinical benefit, although larger trials are underway. https://t.co/vHBlco7RwM

#Didyouknow https://t.co/kQurZW80dP #ISBTScience #ISBT https://t.co/SRp6oZray6

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 11 additional X posts.